Huang, Y., Wu, X., Ren, X., Wu, X., Wan, R., Fei, K., Sun, B., Xu, J., Zhong, J., Wang, Z., Wang, L., Shan, B., Guo, Q., Wang, J., Duan, J. (2026). Sintilimab plus anlotinib and chemotherapy as first-line treatment for advanced malignant pleural mesothelioma (SACH-MPM): A prospective, single-arm, phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8050